These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35073416)

  • 1. Physiological levels of 25-hydroxyvitamin D
    Matos C; Renner K; Peuker A; Schoenhammer G; Schreiber L; Bruss C; Eder R; Bruns H; Flamann C; Hoffmann P; Gebhard C; Herr W; Rehli M; Peter K; Kreutz M
    Scand J Immunol; 2022 May; 95(5):e13146. PubMed ID: 35073416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation.
    Fawaz L; Mrad MF; Kazan JM; Sayegh S; Akika R; Khoury SJ
    Clin Immunol; 2016 May; 166-167():59-71. PubMed ID: 27041081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency in pregnant women impairs regulatory T cell function.
    Vijayendra Chary A; Hemalatha R; Seshacharyulu M; Vasudeva Murali M; Jayaprakash D; Dinesh Kumar B
    J Steroid Biochem Mol Biol; 2015 Mar; 147():48-55. PubMed ID: 25448751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2.
    Chambers ES; Suwannasaen D; Mann EH; Urry Z; Richards DF; Lertmemongkolchai G; Hawrylowicz CM
    Immunology; 2014 Sep; 143(1):52-60. PubMed ID: 24673126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D-binding protein controls T cell responses to vitamin D.
    Kongsbak M; von Essen MR; Levring TB; Schjerling P; Woetmann A; Ødum N; Bonefeld CM; Geisler C
    BMC Immunol; 2014 Sep; 15():35. PubMed ID: 25230725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprint of "Vitamin D deficiency in pregnant women impairs regulatory T cell function".
    Vijayendra Chary A; Hemalatha R; Seshacharyulu M; Vasudeva Murali M; Jayaprakash D; Dinesh Kumar B
    J Steroid Biochem Mol Biol; 2015 Apr; 148():194-201. PubMed ID: 25644204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease.
    Spanier JA; Nashold FE; Mayne CG; Nelson CD; Hayes CE
    J Neuroimmunol; 2015 Sep; 286():48-58. PubMed ID: 26298324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D
    Spanier JA; Nashold FE; Nelson CD; Praska CE; Hayes CE
    J Neuroimmunol; 2020 Jan; 338():577105. PubMed ID: 31731231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of vitamin D
    Behm C; Blufstein A; Gahn J; Kubin B; Moritz A; Rausch-Fan X; Andrukhov O
    J Clin Periodontol; 2020 Jun; 47(6):689-701. PubMed ID: 32160330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages.
    Kreutz M; Andreesen R; Krause SW; Szabo A; Ritz E; Reichel H
    Blood; 1993 Aug; 82(4):1300-7. PubMed ID: 8394753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells.
    Khoo AL; Joosten I; Michels M; Woestenenk R; Preijers F; He XH; Netea MG; van der Ven AJ; Koenen HJ
    Immunology; 2011 Dec; 134(4):459-68. PubMed ID: 22044285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.
    Jeffery LE; Burke F; Mura M; Zheng Y; Qureshi OS; Hewison M; Walker LS; Lammas DA; Raza K; Sansom DM
    J Immunol; 2009 Nov; 183(9):5458-67. PubMed ID: 19843932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1α,25-dihydroxyvitamin D3 acts via transforming growth factor-β to up-regulate expression of immunosuppressive CD73 on human CD4+ Foxp3- T cells.
    Mann EH; Chambers ES; Chen YH; Richards DF; Hawrylowicz CM
    Immunology; 2015 Nov; 146(3):423-31. PubMed ID: 26251265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions.
    Nishikawa M; Yasuda K; Takamatsu M; Abe K; Okamoto K; Horibe K; Mano H; Nakagawa K; Tsugawa N; Hirota Y; Horie T; Hinoi E; Okano T; Ikushiro S; Sakaki T
    Sci Rep; 2020 Mar; 10(1):5677. PubMed ID: 32231239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region.
    Kang SW; Kim SH; Lee N; Lee WW; Hwang KA; Shin MS; Lee SH; Kim WU; Kang I
    J Immunol; 2012 Jun; 188(11):5276-82. PubMed ID: 22529297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.